BPC-157 , ,
How This Works IGF-1 LR3 is a synthetic analog of human insulin-like growth factor-1 engineered with an N-terminal extension (13 amino acids) and a glutamic acid substitution at position 3, resulting in significantly reduced binding affinity to IGF binding proteins [1]
Soeberg and the Soeberg Principal: 27 mins, 30 sec The Cold Shock Response: 31 mins, 40 sec Whats the Ideal Temperature for a Cold Plunge?: 32 mins, 50 sec Cold Exposure and Dopamine: 36 mins, 24 sec Cold Plunge Before or After a Workout?: 38 mins, 24 sec The Effect of Body Temperature on Health, Sleep, and Performance: 43 mins Cold Plunge and Discomfort: 50 mins, 55 sec What is Palm Cooling?: 54 mins, 58 sec Testosterone, Performance Enhancement Drugs, and Recovery: 1 hour, 1 min Rogan and Hubermans Thoughts on Mainstream Media: 1 hour, 7 mins What are the Benefits of Supplements?: 1 hour 11 mins Hubermans Experiences and Thoughts on Scientific Research: 1 hour, 17 mins Epsteins Grants to Labs and Scientists: 1 hour 33 mins Science and Psychedelics, 1 hour, 44 mins Microdosing Psilocybin: 1 hour, 58 mins How Much Water Should I Drink?: 2 hours, 1 min Wellness Practices That Are Ahead of its Time: 2 hours, 5 mins What is Semaglutide/ GLP 1?: 2 hours, 11 mins What is the Best Kind of Diet?: 2 hours, 22 mins What is NAD and Why is it Important?: 2 hours, 30 mins Prescribed Testosterone and the FDA: 2 hours 40 mins Rogan and Huberman discussing science and psychedelics
Combination therapy with HDACi and immune checkpoint inhibitors has shown promise in multiple clinical trials, particularly in patients with refractory tumors, where the combination therapy regimen can significantly improve patient survival rates and disease control rates (7880)
